<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01758107</url>
  </required_header>
  <id_info>
    <org_study_id>monorapa</org_study_id>
    <nct_id>NCT01758107</nct_id>
  </id_info>
  <brief_title>Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients</brief_title>
  <official_title>Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study safety of longterm immunosuppressive protocol with Sirolimus plus Prednisolone, and
      Calcineurin inhibitor withdrawal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sirolimus with Cyclosporine minimization is the standard protocol for kidney transplantation
      in Chulalongkorn University. The investigators published the safety of this regimen in
      Transplantation Proceeding 2008; 40: 2206-8.

      The investigators now further study in those patients who doing well with this regimen more
      than 1 year. The patients will be asked for kidney biopsy to evaluate and make sure they
      don't have subclinical rejection. The patients who don't have subclinical rejection will
      discontinue cyclosporine and continue with only sirolimus and prednisolone.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>longterm glomerular filtration rate defined by eGFR CKD-EPI</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute rejection rate</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Renal Transplant</condition>
  <arm_group>
    <arm_group_label>Sirolimus with Prednisolone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sirolimus with Prednisolone, and withdraw cyclosporine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sirolimus with Cyclosporine with Prednisolone</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Withdraw cyclosporine</intervention_name>
    <arm_group_label>Sirolimus with Prednisolone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Kidney transplant with Sirolimus plus Cyclosporine plus Prednisolone more than 1 year

        Exclusion Criteria:

          -  history of acute rejection, or subclinical rejection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Natavudh Townamchai, MD</last_name>
    <phone>+66894904222</phone>
    <email>ntownamchai@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natavudh Townamchai, MD</last_name>
      <phone>+66894904222</phone>
      <email>ntownamchai@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Natavudh Townamchai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2012</study_first_submitted>
  <study_first_submitted_qc>December 31, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2013</study_first_posted>
  <last_update_submitted>February 1, 2015</last_update_submitted>
  <last_update_submitted_qc>February 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Natavudh Townamchai, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclosporins</mesh_term>
    <mesh_term>Cyclosporine</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

